CA-MRSA is clinically and biologically distinct from HA-MRSA. The epidemiology and incidence of each strain of MRSA is changing and has become a worldwide problem. Understanding differences of these two strains is required to effectively prevent, treat, and manage orthopaedic patients.

Medicare and Medicaid health insurance programs will halt reimbursements for treating hospital-acquired infections and other “preventable” conditions.

Data supporting preoperative decolonization in orthopaedic patients is also limited

The data clearly suggest that S aureus and MRSA should become a national priority for disease control. The more resistant vancomycin-intermediate-sensitive S aureus and vancomycin-resistant S aureus potentially loom as even greater problems. Only vigilant prevention and implementation of the most current treatment protocols will provide an increased margin of safety.

Each year, more than 200,000 individuals are hospitalized and 3,000-49,000 deaths occur from influenza-related complications. 

cough and/or sore throat and a runny or stuffy nose. Influenza frequently causes people to miss school and work but in some cases there are severe complications such as pneumonia

More than 40 million doses of 2015-16 flu vaccine(http://www.cdc.gov/flu/professionals/vaccination/vaccinesupply.htm) have been distributed in the United States

While how well the vaccine works can vary(http://www.cdc.gov/flu/about/qa/vaccineeffect.htm), flu vaccine is the best way to prevent influenza illness and its complications